Rates 2025: assessment of research under CTR, MDR and IVDR

The Ministry of Health, Welfare and Sport has set the rates for 2025 for medical ethical review in the Netherlands of research under CTR, MDR and IVDR. These national rates will apply to assessments by the accredited MRECs and by CCMO. All other rates will continue to apply to the assessment of other clinical research in the Netherlands.

The new rates will apply from 1 January 2025. The rates apply to the assessment of clinical research into:

  • Medicinal products: Research files falling within the scope of the EU Clinical Trials Regulation 536/2014 (CTR) for research with a medicinal product.
  • Medical devices: Research files carried out for conformity purposes, article 62/74.2 of the EU Medical Device Regulation 2017/745 (MDR).
  • In vitro diagnostic medical devices: research files within the scope of Article 58/70.2 of the EU In Vitro Diagnostic Regulation 2017/746, also known as the In Vitro Diagnostic Regulation (IVDR).

Changes compared to 2024 are as follows:

  • All rates are indexed by approximately 4% and then rounded.
  • Rates for safety assessments by the Netherlands have already expired in 2024 and will not return in 2025. Other Member States can, however, charge for their safety assessments.

For more information: